$INBP

$0.18 -$0.01 (5.26%) Close

$INBP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 31.1M shares outstanding

Who owns INBP?

By type of holder

Institutions 0.0% Insiders 100.0% Everyone else 0.0%

Concentration Top 7 holders own 172.7%

Milmoe William H. 56.7% · DeSantis Damon 41.6%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Integrated Biopharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2026

+2.9%

+0.32% a year

Each share's claim on the business

−2.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.82M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding INBP.

Super Investors

Investment managers reporting INBP on Form 13F

No 13F manager reports holding INBP yet.

Institutional Funds

Mutual funds and ETFs reporting INBP on Form N-PORT; together they hold 0.0% of the company

No fund reports holding INBP yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
MW Milmoe William H. Insider	17.6M	56.73%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company56.730% Milmoe William H.'s insider activity →
DD DeSantis Damon 5%+ holder 13D · 41.3%	12.9M	41.60%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company41.600% Disclosed stake13D · 41.3% View the 13D/G filing →

Milmoe William H.

Insider

17.6M

% of company

56.73%

Change vs last qtr

—

Held since

—

DeSantis Damon

5%+ holder13D · 41.3%

12.9M

% of company

41.60%

Change vs last qtr

—

Held since

—

5 more holders behind a free account

See every insider and 5%+ holder of Integrated Biopharma Inc.

Comments